Syndecan-1 translocates to the cell nucleus of various tumor cells, including malignant mesothelioma, fibrosarcoma, neuroblastoma, breast- and lung adenocarcinoma, and multiple myeloma (12, 40–42). Here, SDC1 is linked to AL amyloidosis.